Research and Development

The Research and Development team at Avid Radiopharmaceuticals focuses on creating innovative molecular imaging agents aimed at early detection and management of chronic diseases, particularly those affecting the central nervous system. This diverse group of experts, including chemists, scientists, and statisticians, collaborates on the synthesis, testing, and regulatory pathways of imaging compounds, driving advancements that could lead to transformative changes in clinical practices for conditions like Alzheimer's and Parkinson's disease. Their work supports the overarching mission of enabling pre-symptomatic diagnosis and personalized treatment options.